<prompt> A 58-year-old woman is admitted to hospital with left-sided hemiparesis. She is diagnosed with an ischemic right cortical stroke, and started on amino salicylic acid ASA for secondary prevention. Her carotid ultrasound reveals no arterial stenosis. She has no other significant past medical history but she does smoke half pack a day. Her fasting lipid profile is T-chol 240 mgdL, HDL 50 mgdL, LDL 160 mgdL, and triglycerides 130 mgdL.For the above patient with dyslipidemia, select the most appropriate treatment.fibric acid derivatives clofibrate, gemfibrozilnicotinic acidbile acid-binding resins cholestyramine, colestipolhepatic hydroxymethylglutaryl coenzyme A HMG-CoA reductase inhibitors lovastatin, simvastatin, pravastatin  <response>: Recent evidence has suggested that lipid modification for patients with ischemic stroke that is not cardioembolic in origin by lowering LDL level with statins is beneficial in reducing future stroke risk. This evidence comes from the analysis of cardiovascular statin trials that have a lower rate of ischemic strokes in patients taking the medication as compared to the placebo group. In addition, lifestyle modification is important for this individual, especially smoking cessation. 